Fluent

Fluent FCF Growth

Delisted

The Year-over-Year Free Cash Flow Growth of Fluent (TIUM.U.CN) as of Nov 7, 2026 is -1.25 %. In the previous year, Year-over-Year Free Cash Flow Growth was 146.47 % — a change of -100.85% (lower).

FCF Growth

-1.25 %

YoY

-100.85%

Last updated:

Year-over-Year Free Cash Flow Growth of Fluent is 2023 -1.25 % . Year-over-Year Free Cash Flow Growth of Fluent was 2022 146.47 % . It decreases by -100.85% lower compared to the previous year.

The Fluent FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2020
107.86 USD
Jan 1, 2021
-1,011.77 USD
Jan 1, 2022
146.47 USD
Jan 1, 2023
-1.25 USD
The Fluent FCF Growth history
YEARFCF GrowthYoY
-1.25 %-100.85%
146.47 %-114.48%
-1,011.77 %-1,038.04%
107.86 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fluent Stock analysis

What does Fluent do? Fluent Corp operates under the private label Fluent, selling medical cannabis products in Florida, Texas, and Pennsylvania. The company's products include oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, edibles, and accessories. Subsidiaries such as Cansortium Holdings LLC and Cansortium Florida, LLC handle production and sales, while Fluent Servicing, LLC manages servicing aspects. The company's revenue comes from direct sales of medical cannabis products through its licensed operations in multiple states. Fluent Corp's target customers are patients seeking medical cannabis treatments, with products tailored to various consumption methods. The company leverages its subsidiaries to maintain compliance and expand its market reach across different states. Sales are conducted through licensed dispensaries and medical cannabis programs, focusing on the healthcare segment of the cannabis industry. The business model relies on the production and sale of medical cannabis under the private label Fluent, utilizing subsidiaries to manage state-specific operations. Products are distributed through established medical cannabis channels, with no mention of additional revenue streams beyond product sales. The company's focus remains on the medical cannabis market, serving patients in Florida, Texas, and Pennsylvania. Fluent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluent stock

Year-over-Year Free Cash Flow Growth of Fluent is -1.25 % in 2023.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Fluent since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Fluent historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Fluent

All Key Metrics — Fluent